Medium-Chain Acylcarnitines Are Associated With Cardioembolic Stroke and Stroke Recurrence: A Metabolomics Study.

CONCLUSIONS: Metabolomics provided an improved understanding of CE pathogenesis and stroke recurrence. We have identified decanoylcarnitine and octanoylcarnitine as novel biomarkers for CE and stroke recurrence. PMID: 30026276 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30026276?dopt=Abstract

Source: Arteriosclerosis, Thrombosis and Vascular Biology - July 19, 2018 Category: Cardiology Authors: Seo WK, Jo G, Shin MJ, Oh K Tags: Arterioscler Thromb Vasc Biol Source Type: research